Harel Insurance Investments & Financial Services Ltd.
InsurancePosition in EXEL — Exelixis, Inc.
CIK 1429390
Ramat Gan, L3
Position in EXEL
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$918,984
-$871,587 QoQ
Shares Held
16,890
-59.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#347
of 754 holders
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Harel Insurance Investments & Financial Services Ltd. holds $5,070,384 across 6 Biotechnology names. EXEL ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,837 | $1,905,953 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,822 | $1,759,629 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
16,890 | $918,984 | |
| 4 | INCY |
Incyte Corp
|
3,670 | $416,031 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,550 | $53,196 | |
| 6 | CAPR |
Capricor Therapeutics, Inc.
|
689 | $16,591 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $918,984 | 16,890 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,790,571 | 41,748 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,547,750 | 58,128 | Shares | Defined | 2026-02-03 | |
| 2020-06-30 | $47,480 | 2,000 | Shares | Defined | 2020-07-14 | |
| No filing history on record for this holder in this stock. | ||||||